title: The infrequency of liver function testing in patients using nonsteroidal anti-inflammatory drugs.
abstract: OBJECTIVE
  To describe the monitoring of liver function for patients using nonsteroidal anti-inflammatory drugs (NSAIDs), we reviewed the patterns of liver function testing in a medium-sized health maintenance organization.
  
  
  METHODS
  We examined the interval between start of therapy and first performance of a liver function test during courses of therapy of the NSAIDs diclofenac sodium, naproxen and naproxen sodium, and piroxicam. For comparison, we also studied courses of lovastatin as a "positive control," in which the anticipated frequency of liver function testing was high.
  
  
  RESULTS
  The frequency of liver function tests in patients using NSAIDs was generally low, although testing was more common in patients who used diclofenac. The probability of liver function testing was higher for patients treated in recent calendar years, for patients treated by rheumatologists, for patients who previously used NSAIDs, and for patients who had undergone a liver function test sometime in the 6 months preceding the onset of therapy.
  
  
  CONCLUSIONS
  Physicians ordered liver function tests less frequently than recommended, but the observed testing patterns appear rational in light of the very low reported frequency of serious hepatic disease in large, monitored populations of patients using NSAIDs.
authors: Epidemiology Resources Inc, Newton Lower Falls, Boston, Mass.
authors: A M
authors: AM
authors: Walker
authors: E A
authors: EA
authors: Bortnichak
authors: L
authors: L
authors: Lanza
authors: R A
authors: RA
authors: Yood
mesh_terms: D000368:Aged; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects* / Q000627:therapeutic use; D004008:Diclofenac / Q000009:adverse effects; D005260:Female; D006279:Health Maintenance Organizations; D006801:Humans; D008111:Liver Function Tests / Q000706:statistics & numerical data*; D008148:Lovastatin / Q000009:adverse effects; D008297:Male; D008875:Middle Aged; D009288:Naproxen / Q000009:adverse effects; D010894:Piroxicam / Q000009:adverse effects; D011336:Probability; D013997:Time Factors
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D010894:Piroxicam; D004008:Diclofenac; D009288:Naproxen; D008148:Lovastatin